Friday, November 17, 2017 7:34:16 PM
No, the facts I posted before are more logical and likely. Little average daily volume dominated by daily short trading (except for those coordinated dilution events), no revenue, no forecasted revenue anytime soon, equates to little to no interest. Let's be honest....most stem cell therapies are dubious at best, so even if PSTI products are for real, they battle the public perception of snake oil, irregardless of if it applies to them or not.
You keep pushing the controller fantasy and I'll keep posting the logical market metric reasoning, people that have access to both perspectives can make up their own minds.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM